Dec 30, 2022
Neuroscientists developed a blood-based biomarker for Alzheimer’s diagnosis
Posted by Gemechu Taye in categories: biotech/medical, neuroscience
A significant step toward improved accessibility.
Neuroscientists from the University of Pittsburgh School of Medicine developed a new test to identify a sign of Alzheimer’s disease neurodegeneration in a blood sample, according to a press release.
“At present, diagnosing Alzheimer’s disease requires neuroimaging,” said senior author Thomas Karikari, Ph.D., assistant professor of psychiatry at Pitt.
Continue reading “Neuroscientists developed a blood-based biomarker for Alzheimer’s diagnosis” »